Sihuan sues equity group over Botox trade secrets
30-09-2021
PTAB invalidates Medytox Botox patent
20-07-2021
USITC to investigate Daewoong following Allergan complaint
04-03-2019
Novikov Alex / Shutterstock.com
An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox (onabotulinumtoxinA) to treat back pain.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Allergan, Botox, patent infringement, off-label use, patent
